INDSWFTLAB
Invest Now
Ind-Swift Laboratories Share Price
₹103.00 -1.01 (-0.97%)
21 Nov, 2024 14:16
Start SIP in INDSWFTLAB
Start SIPPerformance
- Low
- ₹102
- High
- ₹104
- 52 Week Low
- ₹90
- 52 Week High
- ₹186
- Open Price₹0
- Previous Close₹104
- Volume11,694
Investment Returns
- Over 1 Month -21.82%
- Over 3 Month -24.61%
- Over 6 Month -6.58%
- Over 1 Year + 9.87%
Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!
Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 2.3
- PEG Ratio
- 0
- Market Cap Cr
- 609
- P/B Ratio
- 0.7
- Average True Range
- 2.85
- EPS
- 17.29
- Dividend Yield
- 0
- MACD Signal
- -4.38
- RSI
- 27.9
- MFI
- 9.5
Ind-Swift Laboratories Financials
Ind-Swift Laboratories Technicals
EMA & SMA
Current Price
₹103.00
-1.01
(-0.97%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹112.93
- 50 Day
- ₹121.18
- 100 Day
- ₹125.02
- 200 Day
- ₹120.73
Resistance and Support
104.33
- R3 105.67
- R2 105.33
- R1 104.67
- S1 103.67
- S2 103.33
- S3 102.67
Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-06-27 | Preferential issue of shares | |
2024-05-13 | Audited Results | |
2024-02-12 | Quarterly Results |
Ind-Swift Laboratories F&O
About Ind-Swift Laboratories
- NSE Symbol
- INDSWFTLAB
- BSE Symbol
- 532305
- Chairman & Managing Director
- Mr. Navrattan Munjal
- ISIN
- INE915B01019
Similar Stocks to Ind-Swift Laboratories
Ind-Swift Laboratories FAQs
Ind-Swift Laboratories share price is ₹103 As on 21 November, 2024 | 14:02
The Market Cap of Ind-Swift Laboratories is ₹608.6 Cr As on 21 November, 2024 | 14:02
The P/E ratio of Ind-Swift Laboratories is 2.3 As on 21 November, 2024 | 14:02
The PB ratio of Ind-Swift Laboratories is 0.7 As on 21 November, 2024 | 14:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.